| Literature DB >> 34940377 |
Diego Omar Sanchez Ramirez1, Iriczalli Cruz-Maya2, Claudia Vineis1, Vincenzo Guarino2, Cinzia Tonetti1, Alessio Varesano1.
Abstract
Protein-based nanofibres are commonly used in the biomedical field to support cell growth. For this study, the cell viability of wool keratin-based nanofibres was tested. Membranes were obtained by electrospinning using formic acid, hexafluoroisopropanol, and water as solvents. For aqueous solutions, polyethylene oxide blended with keratin was employed, and their use to support in vitro cell interactions was also validated. Morphological characterization and secondary structure quantification were carried out by SEM and FTIR analyses. Although formic acid produced the best nanofibres from a morphological point of view, the results showed a better response to cell proliferation after 14 days in the case of fibres from hexafluoroisopropanol solution. Polyethylene oxide in keratin nanofibres was demonstrated, over time, to influence in vitro cell interactions, modifying membranes-wettability and reducing the contact between keratin chains and water molecules, respectively.Entities:
Keywords: cell growth; electrospinning; scaffolds; wool-keratin
Year: 2021 PMID: 34940377 PMCID: PMC8698655 DOI: 10.3390/bioengineering8120224
Source DB: PubMed Journal: Bioengineering (Basel) ISSN: 2306-5354
Electrospinning conditions–all samples were electrospun for 1 h at 22 °C and 28% RH.
| Sample | Solvent | Total Polymer Conc. (%wt.) | Polymer Blend (%wt.) | Flow Rate (mL min−1) | Tip-Collector Distance (cm) | Voltage (kV) | Needle i.d. (mm) |
|---|---|---|---|---|---|---|---|
| KSFA | FA | 15 | 100 KS | 0.002 | 15 | 25 | 0.2 |
| KSHFIP | HFIP | 6 | 100 KS | 0.002 | 15 | 25 | 0.9 |
| KSPEO 1 | Water | 7 | 70/30 KS/PEO | 0.010 | 20 | 25 | 0.2 |
1 KSPEO samples were post-treated to remove PEO as reported in the literature [18].
Figure 1SEM images (number 1) and diameter distribution of NFs (number 2) for samples after post-treatment: (a) KSFA, (b) KSHFIP, (c) KSPEO-180 °C and 24 h in water.
Figure 2FTIR spectra before and after post-treatment at different wavenumber ranges. From (a–d): the first row corresponds to KS-NFs made of pure KS in solvents; (e,f): the second row corresponds to KS-NFs made of KS and PEO in water–KS (lyophilized powder) and PEO (powder).
Protein secondary structure content (%).
| Sample | Intermolecular β–Sheet | Intramolecular β–Sheet | β–Sheet II | β–Turn | Random Coil | α–Helix |
|---|---|---|---|---|---|---|
| KS | 23.9 | 6.5 | 24.2 | 11.3 | 6.7 | 27.4 |
| KSFA-As spun | 21.0 | 4.7 | 21.1 | 20.5 | 25.0 | 7.7 |
| KSFA-180 °C | 20.8 | 6.1 | 17.8 | 20.6 | 27.7 | 7.0 |
| KSHFIP-As spun | 18.3 | 6.3 | 17.5 | 21.2 | 4.0 | 32.6 |
| KSHFIP-180 °C | 19.0 | 7.1 | 18.9 | 21.0 | 4.1 | 29.9 |
| KSPEO-As spun | 20.5 | 0.2 | 25.2 | 26.8 | 19.5 | 7.7 |
| KSPEO-180 °C | 16.7 | 13.9 | 21.9 | 17.5 | 16.4 | 13.6 |
| KSPEO-180 °C, 24 h in water | 23.0 | 4.9 | 19.0 | 22.9 | 18.2 | 12.0 |
Figure 3hMSCs viability cultured in KS-NFs from different solutions: (a) comparison of absorbance between KSFA and KSHFIP; and (b) KS with and without PEO. (* p < 0.05, ** p < 0.01).